Biocartis developed the Idylla™ platform, a fully automated, on-demand molecular diagnostics system. Idylla™ allows for accurate, actionable results, in any setting, with direct impact on treatment choice and rapid treatment initiation. In my current role as Business Director of the Export team, I strive to bring the benefits of Idylla™ to patients globally. My team is responsible for LATAM, East-Europe, Africa, Middle-East and Asia in close collaboration with a fine selection of top distributors. In my previous role as the Market Access Manager I was supporting the launch of Idylla™ tests with focus on price setting, reimbursement and our value proposition to ensure that our products reach their highest commercial potential. Before Biocartis, I worked 10 years in consulting, of which 8 years in the Life Sciences industry. I had a focus on strategic sales and marketing, pricing, market assessment, EMEA wide market access and health economics.